Sectors
HURA
TuHURA Biosciences, Inc.
2.22
42 x 2.21
4 x 2.23
bid
ask
+
0.01
0.45%
10:04 AM
timesize
| Ytd | 193.38% | |
| 1y | -18.98% |
2.21
day range
2.25
0.41
52 week range
3.90
| Open | 2.24 | Prev Close | 2.21 | Low | 2.21 | High | 2.25 | Mkt Cap | 140.74M |
| Vol | 12.75K | Avg Vol | 637.96K | EPS | -0.60 | P/E | -3.65 | Forward P/E | -14.31 |
| Beta | -0.05 | Short Ratio | N/A | Inst. Own | N/A | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-13 | 50-d Avg | 2.33 | 200-d Avg | 1.86 | 1yr Est | 15.00 |
| Income Statement | |||
| Operating Expenses | 7.53M | ||
| Research and Development Expense | 5.23M | ||
| Selling, General and Administrative Expense | 2.30M | ||
| Operating Income | -7.53M | ||
| Interest Expense | 27.97K | ||
| Net Income | -7.54M | ||
| Net Income Common Stock | -7.54M | ||
| Net Income Common Stock (USD) | -7.54M | ||
| Consolidated Income | -7.54M | ||
| Earnings per Basic Share | -0.13 | ||
| Earnings per Basic Share (USD) | -0.13 | ||
| Earnings per Diluted Share | -0.13 | ||
| Earning Before Interest & Taxes (EBIT) | -7.51M | ||
| Earning Before Interest & Taxes (USD) | -7.51M | ||
| Preferred Dividends Income Statement Impact | 2.09K | ||
| Weighted Average Shares | 60.01M | ||
| Weighted Average Shares Diluted | 60.01M | ||
| Balance Sheet | |||
| Cash and Equivalents | 6.30M | ||
| Cash and Equivalents (USD) | 6.30M | ||
| Current Assets | 6.98M | ||
| Property, Plant & Equipment Net | 675.65K | ||
| Total Assets | 29.70M | ||
| Debt Current | 206.85K | ||
| Total Debt | 456.93K | ||
| Current Liabilities | 6.07M | ||
| Debt Non-Current | 250.08K | ||
| Total Liabilities | 6.51M | ||
| Accumulated Retained Earnings (Deficit) | -148.72M | ||
| Shareholders Equity | 23.19M | ||
| Shareholders Equity (USD) | 23.19M | ||
| Assets Non-Current | 22.72M | ||
| Total Debt (USD) | 456.93K | ||
| Goodwill and Intangible Assets | 10.74M | ||
| Liabilities Non-Current | 447.99K | ||
| Trade and Non-Trade Payables | 5.86M | ||
| Tax Liabilities | 197.92K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 23.47K | ||
| Net Cash Flow from Financing | 7.14M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 2.68M | ||
| Capital Expenditure | -48.85K | ||
| Issuance (Purchase) of Equity Shares | 7.50M | ||
| Issuance (Repayment) of Debt Securities | -208.20K | ||
| Net Cash Flow from Investing | -48.85K | ||
| Net Cash Flow from Operations | -4.41M | ||
| Share Based Compensation | 2.80M | ||